Scinai Immunotherapeutics Ltd. (FRA:2F5)
Germany
· Delayed Price · Currency is EUR 0.9150
+0.0200 (2.23%)
Last updated: Dec 5, 2025, 9:59 AM CET
Scinai Immunotherapeutics Revenue
Scinai Immunotherapeutics had revenue of $386.50K USD in the quarter ending June 30, 2025, with 36.09% growth. This brings the company's revenue in the last twelve months to $1.15M, up 303.87% year-over-year. In the year 2024, Scinai Immunotherapeutics had annual revenue of $658.00K.
Revenue (ttm)
$1.15M
Revenue Growth
+303.87%
P/S Ratio
3.37
Revenue / Employee
$37.00K
Employees
31
Market Cap
3.29M EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |